Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.5800
0.00 (0.00%)
Feb 6, 2026, 4:00 PM EST

BCLI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
6131360145143
Market Cap Growth
-48.27%-3.18%-77.69%-58.70%1.59%47.63%
Enterprise Value
7141557123116
Last Close Price
0.582.274.0924.6060.0067.87
PB Ratio
-0.83-1.67-2.75-19.887.504.03
P/TBV Ratio
----7.514.03
Debt / Equity Ratio
-0.06-0.13-0.26-1.360.260.20
Quick Ratio
0.010.030.170.353.513.76
Current Ratio
0.060.040.240.353.693.85
Return on Equity (ROE)
----297.38%-89.25%-273.75%
Return on Assets (ROA)
-400.07%-241.99%-211.70%-82.24%-38.09%-68.53%
Return on Capital Employed (ROCE)
142.60%163.60%596.90%7112.30%-106.90%-79.20%
Earnings Yield
-170.20%-89.78%-128.57%-40.51%-16.85%-22.27%
FCF Yield
--70.23%-153.13%-32.29%-18.33%-24.90%
Buyback Yield / Dilution
-78.11%-74.87%-17.99%-0.91%-21.22%-36.25%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.